Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy

Biosynthetic human insulin and insulin analogues are the mainstay of insulin therapy for both type 1 and type 2 diabetes although access to human insulin at affordable prices remains a global issue. The world is experiencing an exponential rise in the prevalence of diabetes presenting an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbanya, Jean Claude, Sandow, Juergen, Landgraf, Wolfgang, Owens, David R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813441/
https://www.ncbi.nlm.nih.gov/pubmed/29632602
http://dx.doi.org/10.17925/EE.2017.13.01.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813441/
https://www.ncbi.nlm.nih.gov/pubmed/29632602
http://dx.doi.org/10.17925/EE.2017.13.01.21

Ejemplares similares